Advocacy services for adults with health and social care needs: draft scope consultation
We are listening to your views on this NICE guideline. Comments close 22 January 2021.
Search results
13 results
-
-
Heart valve disease presenting in adults: investigation and management: draft guidance consultation
We are listening to your views on this NICE guideline. Comments close 29 April 2021.
-
Weight Management: draft scope consultation
We are listening to your views on this NICE guideline. Comments close 07 May 2021.
-
Type 1 diabetes in adults: diagnosis and management (update): draft guidance consultation
We are listening to your views on this NICE guideline. Comments close 19 May 2021.
-
Magnetic resonance therapy for knee osteoarthritis: interventional procedure consultation
We are listening to your views on this interventional procedures guidance. Comments close 26 April 2021.
-
Hysteroscopic removal of uterine fibroids with power morcellation: interventional procedure consultation
We are listening to your views on this interventional procedures guidance. Comments close 26 April 2021.
-
Laparoscopic morcellation of uterine fibroids: interventional procedure consultation
We are listening to your views on this interventional procedures guidance. Comments close 26 April 2021.
-
Radiofrequency ablation for palliation of painful spinal metastases: interventional procedure consultation
We are listening to your views on this interventional procedures guidance. Comments close 24 May 2021.
-
Lateral elbow resurfacing for arthritis: interventional procedure consultation
We are listening to your views on this interventional procedures guidance. Comments close 24 May 2021.
-
Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea [ID1499]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 28 April 2021.
-
Nivolumab with ipilimumab and chemotherapy for untreated advanced non-small-cell lung cancer [ID1566]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 26 April 2021.
-
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for moderate rheumatoid arthritis after conventional DMARDs have failed (partial review of TA375) [ID2710]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 28 April 2021.
-
Fenfluramine for treating seizures associated with Dravet syndrome [ID1109]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 10 May 2021.